Renaissance Capital logo

Cytek BioSciences Priced, Nasdaq: CTKB

Provides cell analysis instruments for life science applications.

Industry: Health Care

Latest Trade: $26.05 +2.14 (+9.0%)

First Day Return: +10.4%

Return from IPO: +40.6%

Industry: Health Care

We are a leading cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Our goal is to become the premier cell analysis company through continued innovation that facilitates scientific advances in biomedical research and clinical applications. We believe our core instruments, the Aurora and Northern Lights systems, are the first full spectrum flow cytometers able to deliver high-resolution, high-content and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells (“Full Spectrum Profiling” or “FSP”). Our novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Our patented FSP technology optimizes sensitivity and accuracy through its novel optical and electronic designs that utilize an innovative method of light detection and distribution. Our FSP platform includes instruments, reagents, software and services to provide a comprehensive and integrated suite of solutions for our customers. Since our first U.S. commercial launch in mid-2017 through March 31, 2021, we have sold and deployed over 750 instruments—primarily comprised of our Aurora and Northern Lights systems—to over 620 customers around the world, including the largest pharmaceutical companies, over 125 biopharma companies, leading academic research centers, and clinical research organizations (“CROs”).
more less
IPO News for Cytek BioSciences
more
IPO Data
IPO File Date 07/02/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 16.7
Deal Size ($mm) $285
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/22/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 16.7
Deal Size ($mm) $285
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Fremont, CA
Founded 2014
Employees 391
Website cytekbio.com